SCHEMBL3169342

SCHEMBL3169342

CC(=O)NCCNc1cc(NC(=O)CN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 3/20 0.45
▸ CA2 P00918 3/20 0.45
▸ CA7 P43166 3/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ HTT P42858 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ USP2 O75604 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162235 0.94 SMN1; SMN2 (0.48) CA1CA2CA7SMN1; SMN2ALDH1A1
SCHEMBL3172420 0.91 DRD2 (0.46) CA1CA2CA7SMN1; SMN2ALDH1A1
SCHEMBL3161698 0.87 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1MEN1KMT2AHTT
SCHEMBL3171582 0.85 MEN1 (0.47) ALDH1A1MEN1KMT2ANPSR1GAA
SCHEMBL3171920 0.84 ADORA1 (0.47) ALDH1A1KDM4EATM
SCHEMBL3164705 0.84 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1MEN1KMT2AHTT
SCHEMBL3163144 0.83 ADORA3 (0.46) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL3163125 0.83 NPC1 (0.47) ALDH1A1KDM4EMEN1KMT2ANPSR1
SCHEMBL3164709 0.83 NPC1 (0.47) ALDH1A1KDM4EMEN1KMT2ANPSR1
SCHEMBL3162785 0.83 MEN1 (0.54) SMN1; SMN2ALDH1A1MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback